First-to-market Pfizer expects a whopping $15B from its COVID-19 shot in 2021 by Eric Sagonowsky | Feb 2, 2021 11:54am Pfizer laid out its 2021 financial expectations on Tuesday.(Tracy Staton)ShareFacebookTwitterLinkedInEmailPrint More and more COVID-19 vaccines are nearing the market, but mRNA shots from Pfizer and Moderna are still working off a head start in the global rollout. Now,Continue reading “Fierce Pharma Show There is Gold in Them Thar Hills in COVID Vaccine Gold Rush”
A Bird's Eye View of Fashion, Food, Travel, Culture, Beverage and Curiosity 